M.A. and B.A., economics, Université Laval
Summary of Experience
Mr. Vekeman specializes in health economics and health policy, as well as antitrust and product liability matters, with a particular focus on biostatistics and the economics of health outcomes research. He has supported academic affiliates and has conducted and directed a wide range of investigations, including epidemiological evaluations, safety studies, direct and indirect cost-of-illness assessments, and examinations of resource utilization patterns in the areas of cancer, chronic kidney disease, hypertension, hematology, HIV, cardiovascular disease, pulmonary disease, and mental illness, among others. Through these investigations, he has collected and utilized data from clinical trials, medical records review, automated health insurance claims, spontaneous adverse event reports (Med Watch, VigiBase), and population-based surveys. His scientific research on various health topics -- including hospitalization risk and associated costs, medical costs of various illnesses, drug cost-effectiveness, and signaling analysis -- has been published in peer-reviewed journals and presented at health care conferences and to the U.S. Food and Drug Administration, the European Medical Agency, and the Centers for Medicare & Medicaid Services. He is a member of and reviewer for the International Society for Pharmacoeconomics and Outcomes Research. Mr. Vekeman's experience in antitrust and product liability matters includes quantifying economic damages resulting from false advertising claims, analyzing copyright infringement, and reviewing unfair competition issues.